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Available online 6 September 2018AbstractPurpose: To determine the effect of isotretinoin on corneal sensitivity in acne patients.
Methods: Fifty patients (13 men and 37 women) with a mean age of 23.24 ± 3.4 years were selected among patients receiving isotretinoin
(1.0 mg/kg) for acne according to inclusion criteria. The Cochet-Bonnet esthesiometer was used to measure corneal sensitivity (in mm filament
length) two times (the measurements were done immediately before starting the medication, then 3 months after that), including 3 measurements
each time, between 11 a.m. and 1 p.m. by an experienced operator. The average of the 3 measurements in each time was recorded as the final
value. One-way analysis of variance and Chi square were used for quantitative and qualitative comparison of corneal sensitivity before and after
isotretinoin use, respectively.
Results: The mean corneal sensitivity was 5.54 ± 0.05 before medication consumption which decreased to 5.41 ± 0.05 after isotretinoin
treatment for 3 months (P < 0.005). After controlling the effect of age and sex, the decrease of corneal sensitivity was markedly significant
(P ¼ 0.003) as decreased corneal sensitivity was more pronounced at higher ages and in female gender. In non-parametric evaluation, corneal
sensitivity was categorized as substantial (5.5e6 mm), intermediate (4.5e5.5 mm), and low (3.5e4.5). About 72% of the participants had
substantial corneal sensitivity before drug consumption, which decreased to 60% after 3 months of treatment.
Conclusions: According to the results of this study, corneal sensitivity decreases after three months of treatment with isotretinoin. This decrease
is more pronounced at higher ages and in women.
Copyright © 2018, Iranian Society of Ophthalmology. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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A normal corneal sensitivity is important to the mainte-
nance of normal corneal structure and function. Corneal
sensitivity may markedly decrease in some ocular and sys-
temic diseases, some physiological conditions, and following
the use of certain drugs and ocular surgical procedures.1
Aging, pregnancy, and eyelid occlusion for a long time are
among the physiological conditions leading to decreased
corneal sensitivity.2,3 A number of pathological conditionsosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND
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dystrophy, keratoconus, and trachoma also reduce corneal
sensitivity.4e6 Corneal innervation not only provides corneal
sensitivity, but is also vital to the maintenance of corneal
structure and function for preservation of corneal integrity and
epithelial would healing following diseases, trauma, or sur-
gery.7 In fact, corneal nerves play an important role in pro-
tecting the cornea from stimuli and its nutrition.8,9 According
to the literature, corneal dryness is an important factor in
decreased corneal sensitivity.4,10,11 Certain medication such as
isotretinoin, antihistamine, anticholinergics, and oral contra-
ceptive pills cause dry eye.12 Isotretinoin is now widely used
for the treatment of acne.13 Acne is a common skin inflam-
matory condition14,15 affecting approximately 9.4% of the
world's population, making it the 8th most common disease
worldwide.16 Different treatments have been proposed for
different severities of acne. Regarding the fact that acne-
generating microorganisms show resistance to conventional
antibiotics,17 oral isotretinoin is commonly used to treat this
skin disease instead.18 It should be noted that it is the only
effective drug against all factors involved in acne.19 The side
effects of isotretinoin range from eyelid and corneal changes
to lacrimal abnormalities resulting in dry eye.20e22 Dry eye is
the most common side effect associated with isotretinoin
consumption which may be related to the atrophy of lacrimal
glands and changes in the tear film quality.23 There are reports
of the effect of this medication on dry eye,10 meibomian
glands,13 conjunctival goblet cells,20 visual acuity,22 retina,24
intraocular pressure,25 color vision,26 and corneal topo-
graphic and biomechanical properties.14
Several studies have assessed the effect of dry eye on
corneal sensitivity.4,10,11 Given the widespread use of isotret-
inoin and the resulting dry eye following its use, it is a matter
of debate whether this medication affects corneal sensitivity.
Some systemic medications such as chloroquine and contra-
ceptive pills decrease corneal sensitivity.27 However, we found
no evidence of the effect of isotretinoin on corneal sensitivity
in the literature. The effect of the mentioned drugs on corneal
sensitivity and the importance of corneal sensitivity in pro-
tecting the cornea from stimuli, corneal wound healing,
corneal reflex, lacrimal flow, and maintenance of the corneal
structure and health as well as the widespread use of isotret-
inoin encouraged us to investigate the effect of isotretinoin on
corneal sensitivity in a well-designed study.
Methods
Fifty-eight individuals participated in this interventional
prospective case series study. Five were excluded due to lack
of cooperation to touching the Cochet-Bonnet filament with
their eyes, and 3 were lost to follow-up, so our study continued
with 13 men and 37 women. The statistical population of the
study was individuals who visited a selected skin and hair
clinic for acne, were 18e36 years old, received isotretinoin at
a certain dose (1.0 mg/kg/day), did not receive eye drops
during treatments with isotretinoin, and were willing to
participate in the study. After coordination with the managerof the skin and hair clinic, informed consent was taken from
all volunteers, and the protocol of the study was explained to
them. The Ethics Committee of Iran University of Medical
Sciences approved the study protocol, which was conducted in
accord with the tenets of the Declaration of Helsinki. All
participants signed a written informed consent.
The participants were selected based on the inclusion
criteria (age 18e33 years, having acne, and taking isotreti-
noin as the only drug). The participants with systemic or
ocular diseases (infections, allergies, dystrophies, injuries),
positive history of ocular surgery, corneal scars, contact lens
use, or severe dry eye were excluded from the study due to
the effect of these conditions on corneal sensitivity. The
method of corneal sensitivity measurement was explained to
the participants, and they were assured that the test was
harmless and painless. An experienced person measured
corneal sensitivity in the corneal center using the Cochet-
Bonnet esthesiometer. This esthesiometer works based on
pressure applied vertically through a nylon filament with a
diameter of 0.012 mm2 and a length varying from 5 to
60 mm. Although the Cochet-Bonnet test is a standard clin-
ical test for corneal sensitivity, a positive response mainly
depends on the patient's perception and insight. Since other
methods (air puff, chemical stimulation by capsaicin, and
thermal stimulation by carbon dioxide laser) are expensive
and difficult to carry around, the Cochet-Bonnet method is
still the routine clinical method to measure corneal sensitivity
with a high repeatability and reliability.28 Certain precautions
like regulation of humidity, temperature, and light were
practiced to provide a similar condition for all measurements.
Since studies have shown that corneal sensitivity is different
at different times of the day,29 all measurements were done at
a specific time (between 11 a.m. and 1 p.m.) before and after
drug use. Corneal sensitivity was measured three times in
each eye, and the mean value of three measurements was
recorded. The patient sat on a chair and looked straight for-
ward. Using the handheld Cochet-Bonnet esthesiometer, a
nylon monofilament with maximum length (60 mm) was
slowly moved towards the corneal center vertically. Contact
was determined by mild folding the filament (5% of its free
length), and the patient was asked to report when (s)he felt its
contact. If the patient was unable to feel the contact at full
length, the filament was retracted incrementally in 0.5 mm
steps until the contact of the filament with the central cornea
was felt. The test was repeated three times, and the mean
filament length when contact was felt was recorded as the
corneal sensitivity threshold. The length was converted to
pressure using a conversion table. Measurements were done
for both eyes. Since no marked difference was observed be-
tween the results of the right and left eye of each patient, the
mean value of both eyes was used for analysis. All mea-
surements were done by one person. After measurements, the
filament was sterilized with ethanol. After treatment with
isotretinoin for 3 months at a dose of 1.0 mg/kg/day, corneal
sensitivity was again measured in these patients.
The SPSS software was used to analyze the data of pre and
post drug consumption. Considering the correlation between
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Generalized Linear Models method of analysis was used.
However, because our sampling was rather discrete, and
corneal sensitivity changed in 0.5 cm steps, the data seemed to
be qualitative rather than quantitative.
Results
One hundred eyes of 50 volunteers (13 men and 37 women)
with a mean age of 23.24 ± 3.4 years (18e33 years) were
evaluated. The mean corneal sensitivity was 5.54 ± 0.05 mm
before drug use which decreased to 5.41 ± 0.05 mm after
treatment with isotretinoin for 3 months. Generalized Linear
Models was used to compare corneal sensitivity before and
after medication use, which showed a significant difference
[P ¼ 0.002; coef: 0.125 95% confidence intervals (CI):
0.046e0.204]; after controlling the effect of sex and age in
corneal sensitivity showed a significant difference compared to
the value before drug usage (P < 0.001).
After categorizing corneal sensitivity as low, moderate, and
substantial, we found that 5%, 23%, and 72% of the patients
had low, moderate, and substantial corneal sensitivity before
medication consumption and 6%, 34%, and 60% of the pa-
tients had low, moderate, and substantial corneal sensitivity
after medication used for three months, respectively. McNe-
mar's test showed a significant difference before and after drug
use (P ¼ 0.009).
Discussion
Our prospective case series study showed a significant
decrease in corneal sensitivity after using isotretinoin for 3
months. This decrease was more pronounced in women and at
older ages. There is no evidence of decreased corneal sensi-
tivity after isotretinoin consumption in the literature, but its
adverse effects on the eye have been evaluated. Polat,30
Miera,31 Franfelder,26 and Ayseoner15 assessed the adverse
effects of isotretinoin on the eye and reported decreased
lacrimal flow and dry eye as the main adverse effects.
In 2016, Polat et al.30 conducted a study on 25 patients (16
women and 9 men) who received oral isotretinoin to evaluate
its effect on contrast sensitivity and lacrimal secretion. The
treatment period was 4e7 months in this study, and the pa-
tients underwent Schirmer's test in both eyes before and after
drug consumption. There was a significant decrease in the
lacrimal flow after oral consumption of isotretinoin. Similarly,
Karalezli reported a tear break up time (TBUT) of 12.84 s
before treatment which decreased to 7.84 s 30 days after the
start of treatment, indicating the development of dry eye after
using the drug for one month.32 In 2015, Mayo et al. evaluated
the effect of isotretinoin on meibomian glands. Despite the
normal appearance of the structure of meibomian glands in
imaging studies, there were some signs of palpebral margin
inflammation and decreased secretory function of these
glands. Moreover, the symptoms of dryness largely affected
the patients' quality of life.13 However, the question is how
isotretinoin affects corneal sensitivity. We found a markeddecrease in the corneal sensitivity after treatment with iso-
tretinoin for three months, but does the same mechanism
causing dry eye decrease corneal sensitivity, as well? Some
studies have shown that corneal sensitivity decreases as a
result of dry eye.4,10,11 Bourcier et al. conducted a study to
evaluate corneal sensitivity in patients with dry eye in 2005.
They included 44 patients with dry eye and 42 healthy subjects
as the control group in their study and used the Belmonte's
non-contact gas esthesiometer to measure corneal sensitivity
in all participants. The results showed that dry eye patients had
decreased corneal sensitivity to mechanical, chemical, and
thermal stimulation as compared to the control group, prob-
ably due to decreased number of active nerve terminals as a
result of pathological changes in corneal superficial layers.
Therefore, dryness resulting from drug consumption could
cause decreased corneal sensitivity.
In another study, Queiroga et al.20 evaluated the effect of
isotretinoin on conjunctival goblet cells after three months of
isotretinoin treatment, and found that non-keratinized
conjunctival epithelial cells were pathologically keratinized
and transformed to non-secretory epithelial cells, resulting in
a decrease in the number of mucin-producing goblet cells.
Therefore, isotretinoin could decrease tear quality through
interfering with mucin-production. We found no study ruling
out the effect of isotretinoin on lacrimation; hence, it seems
rational to conclude that isotretinoin consumption, in addi-
tion to causing dry eye, decreases corneal sensitivity. How-
ever, more studies are required to confirm whether or not dry
eye leads to decreased corneal sensitivity. Furthermore,
isotretinoin decreases lipid secretion by about 90% within 6
weeks through decreasing the size of meibomian glands and
the number of sebocytes, and inhibiting lipid production.33
Ding et al. found that isotretinoin altered the gene expres-
sion of meibomian gland epithelial cells, decreased the ac-
tivity of cell survival mediators, inhibited cell proliferation,
and increased cell death.33 Since meibomian glands produce
the lipid layer of the tear film, which is one of the main
layers providing a smooth optical surface for the cornea and
preventing tear evaporation,34 it could be concluded that
damage to the activity of meibomian glands results in
decreased production of the tear film lipid layer, increased
tear film evaporation, and dryness of the eye surface. In fact,
dry eye following the use of isotretinoin is associated with
pathologic changes of the meibomian glands rather than
decreased function of lacrimal glands. It is believed that in
people with dry eye, decreased corneal sensitivity is asso-
ciated with disorders in the integrity of the ocular surface
because corneal sensory nerves may adapt to decreased
frequency and intensity of action potential. When nerve
terminals are damaged, they lose their capability to transfer
energy, leading to decreased number of healthy terminals
capable of transmitting normal stimuli and increased number
of damaged axons in different stages of frequency genera-
tion, resulting in abnormal impulses.11 We noticed a
decrease in corneal sensitivity following the use of isotreti-
noin, which was more pronounced in the female gender and
at older ages.
329N. Fouladgar et al. / Journal of Current Ophthalmology 30 (2018) 326e329The current study has its own strengths and weaknesses.
The strength of our study is that so far, few studies have been
conducted considering the effect of isotretinoin on corneal
sensitivity. On the other hand, lack of control group, placebo
effect, and the low sample size are considered to be the lim-
itations of this study. Since the Cochet-Bonnet esthesiometer
can only measure mechanical sensitivity of the cornea and
suffers limitations in the sensitivity and repeatability of the
measurements, and because we only evaluated corneal sensi-
tivity after 12 weeks of treatment with isotretinoin due to time
limitations, we also recommend doing in vivo confocal mi-
croscopy of corneal nerve for documenting corneal nerve
damage by oral isotretinoin.
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